Epigenetic therapy in human choriocarcinoma. - Wikidata - wikimedia - TriplyDB

Epigenetic therapy in human choriocarcinoma.

Epigenetic therapy in human choriocarcinoma.

http://www.wikidata.org/entity/Q37334277

about

A new approach combining LC-MS and multivariate statistical analysis for revealing changes in histone modification levels.

P2860

Q38962129-6933369C-95AC-479B-B569-A276F08DB8C6

P2860

Epigenetic therapy in human choriocarcinoma.

http://www.wikidata.org/entity/Q37334277

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 10 September 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Epigenetic therapy in human choriocarcinoma.

@en

Epigenetic therapy in human choriocarcinoma.

@nl

type

label

Epigenetic therapy in human choriocarcinoma.

@en

Epigenetic therapy in human choriocarcinoma.

@nl

prefLabel

Epigenetic therapy in human choriocarcinoma.

@en

Epigenetic therapy in human choriocarcinoma.

@nl

P1433

Q37334277-F48388DE-15F4-4B29-8E0D-B96745048BED

P1476

Q37334277-8A858348-5754-4BFD-9ADB-A61B0B14E254

P2093

Q37334277-C372A36B-E530-4101-8650-1B6957383505

Q37334277-D70E0238-FF13-4A44-9AFA-7BD9C85EBFD7

P2860

Q37334277-1765F79B-903A-4311-BB34-1F4438A10B3D

Q37334277-2E98F1CB-E019-471A-871C-A0214AD00740

Q37334277-378B1008-7CF5-4166-B0AF-E59A6E0BA309

Q37334277-4B6D4831-BA72-41FA-A8ED-D34939CB79FC

Q37334277-505FB1F8-3ADB-4EB3-8AF1-0B209EB4A6DB

Q37334277-663170A5-E2CD-40A1-BD51-698FB466658B

Q37334277-6C52E4F4-C1C6-462D-B252-8C4DC7DA2DB7

Q37334277-78A9368C-82C8-4F17-BFD0-C7C6BC907A85

Q37334277-8117C899-3E09-44C1-A260-01CDB13A5A50

Q37334277-836D5037-C055-4BFD-A7CA-7515CD52AE51

P304

Q37334277-272F1CE6-AB10-4676-A159-257B08DA0D4B

P31

Q37334277-E5F5F9F2-70F9-427C-883C-7FEA99940CEF

P356

Q37334277-B108FF58-F53E-4BBF-AEC3-61E678AC3512

P433

Q37334277-BECC0DB4-1F47-40E2-9E24-068E7454797B

P478

Q37334277-620A2D89-27D2-4467-90B1-517FAFE26137

P577

Q37334277-E9236DBC-B822-4437-A152-AFECBFB180FE

P5875

Q37334277-BF768FB6-7F00-4A95-8649-B68EA682B047

P698

Q37334277-AAE6BD39-196B-4B93-AB17-A66008938505

P932

Q37334277-C1FFFE9E-B094-44C5-AB6E-C9D0923E3282

P356

P1433

P1476

Epigenetic therapy in human choriocarcinoma.

@en

P2093

Hisashi Narahara

http://www.w3.org/2001/XMLSchema#string

Noriyuki Takai

http://www.w3.org/2001/XMLSchema#string

P2860

Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents

Translating the Histone Code

The many roles of histone deacetylases in development and physiology: implications for disease and therapy

The language of covalent histone modifications

The histone deacetylase inhibitor and chemotherapeutic agent suberoylanilide hydroxamic acid (SAHA) induces a cell-death pathway characterized by cleavage of Bid and production of reactive oxygen species

Anticancer activities of histone deacetylase inhibitors

Vorinostat in solid and hematologic malignancies

Modified triple chemotherapy in the management of high-risk metastatic gestational trophoblastic tumors.

Intrinsic apoptotic and thioredoxin pathways in human prostate cancer cell response to histone deacetylase inhibitor

Histone deacetylase (HDAC) inhibitor activation of p21WAF1 involves changes in promoter-associated proteins, including HDAC1

P304

1683-1688

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3390/CANCERS2031683

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2010-09-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258955026

http://www.w3.org/2001/XMLSchema#string

P698

24281181

http://www.w3.org/2001/XMLSchema#string

P932

3837331

http://www.w3.org/2001/XMLSchema#string